SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovative vascular...
TAIPEI, Jan. 14, 2026 /PRNewswire/ -- The Pop Institute Taiwan (P.O.P.), a personal development organization dedicated to helping individuals realize their potential, partnered with...
SHENZHEN, China, Jan. 16, 2026 /PRNewswire/ -- On January 7, 2026, the AKG and Ca-AKG of Xin Tianhe Biotechnology successfully completed the Self-GRAS scientific...